Suggested Supplements Kaempferol – Page 9

Microglial phenotype in DS

Trisomy 21 produces:

•  Early microglial hypertrophy, shortened processes, rod-like forms, and elevated Iba1, CD68 and Lamp1

•  Chronically elevated IL-1β, IL-6, IL-8 and interferon-stimulated genes (Hsa21 interferon-receptor dosage plus USP25 overexpression)

•  Increased phagocytic activity that can become maladaptive

•  Later dystrophic/senescent microglia that fail to contain amyloid and tau once APP dosage drives Alzheimer-type pathology

These changes interact with redox imbalance and amyloid, amplifying synaptic loss. pmc.ncbi.nlm.nih.gov 

Kaempferol’s principal microglial targets that map onto this phenotype

NLRP3 inflammasome and IL-1β

Kaempferol interrupts NLRP3 oligomerization, promotes ubiquitin-dependent autophagic/mitophagic degradation of NLRP3, and thereby lowers caspase-1 activation and mature IL-1β. Because IL-1β is already elevated in pediatric and young-adult DS cortex, this is a high-priority node. Recent work also shows kaempferol stimulates mitophagy, reducing mtDNA leakage that otherwise primes NLRP3—an attractive mechanism given the mitochondrial dysfunction inherent to trisomy 21. tandfonline.com 

M1-to-M2 polarization

Kaempferol activates PPARγ while suppressing nuclear p-STAT1, shifting microglia from a CD16/32–iNOS–TNF-α state toward CD206–Arg-1–IL-10. The same PPARγ–STAT1 axis is relevant to the interferon-driven “interferonopathy” of DS. sciencedirect.com 

TLR4 / NF-κB / MAPK cascade

It down-regulates TLR4, HMGB1 release, p38/JNK phosphorylation and NF-κB p65 nuclear translocation, reducing iNOS, COX-2, TNF-α and IL-6. These pathways are constitutively engaged in DS microglia. dx.doi.org 

Oxidative stress and NADPH oxidase

Kaempferol inhibits NOX4, lowers ROS and activates Nrf2/HO-1. DS cells already operate under chronic oxidative load; reducing this feed-forward loop should dampen both inflammasome priming and microglial morphological activation.

Blood–brain-barrier and peripheral–central immune crosstalk

Kaempferol preserves tight-junction proteins and lowers circulating LPS-driven signals. Given the gut–immune dysregulation and sleep-apnea comorbidities common in DS, this peripheral action may secondarily reduce CNS microglial recruitment.